Naftopidil reduced the proliferation of lung fibroblasts and bleomycin‐induced lung fibrosis in mice
Author:
Affiliation:
1. Department of Respiratory Medicine, Graduate School of Medicine University of Tokyo Tokyo Japan
2. Department of Analytic Human Pathology Nippon Medical School Tokyo Japan
Funder
Japan Society for the Promotion of Science
Publisher
Wiley
Subject
Cell Biology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14255
Reference26 articles.
1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
2. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
3. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
4. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
5. Naftopidil, a Novel α1-Adrenoceptor Antagonist, Displays Selective Inhibition of Canine Prostatic Pressure and High Affinity Binding to Cloned Human α1-Adrenoceptors
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aerosolized ⍺1adrenoreceptor antagonism does not affect experimentally induced lung fibrosis in animal models;2023-12-14
2. α1 Adrenoreceptor antagonism mitigates extracellular mitochondrial DNA accumulation in lung fibrosis models and in patients with idiopathic pulmonary fibrosis;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-05-01
3. α1 adrenoreceptor antagonism mitigates extracellular mitochondrial DNA accumulation in lung fibrosis models and in patients with IPF;2022-04-14
4. Drug Repositioning of the Phenylpiperazine Derivative Naftopidil in Prostate Cancer Treatment;Biomedical Translational Research;2022
5. High‐fluence light emitting diode‐red light inhibits cell cycle progression in human dermal fibroblasts;Journal of Biophotonics;2020-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3